Detalhe da pesquisa
1.
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.
Breast Cancer Res
; 25(1): 103, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653397
2.
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials.
Ann Oncol
; 34(11): 1003-1014, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673211
3.
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Ann Oncol
; 34(4): 397-409, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709040
4.
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Ann Oncol
; 33(8): 769-785, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605746
5.
Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer.
Breast Cancer Res Treat
; 192(2): 293-301, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34982322
6.
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival.
Ann Oncol
; 32(8): 1015-1024, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102253
7.
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.
Ann Oncol
; 32(10): 1256-1266, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34384882
8.
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer.
Breast Cancer Res Treat
; 185(1): 183-194, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980945
9.
Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
Breast Cancer Res Treat
; 186(3): 715-722, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452953
10.
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Gynecol Oncol
; 157(1): 245-251, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980219
11.
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival.
Breast Cancer Res Treat
; 176(3): 597-605, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065871
12.
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
Ann Oncol
; 29(4): 888-894, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360932
13.
Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785].
Ann Oncol
; 34(3): 326, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529568
14.
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.
Breast Cancer Res Treat
; 171(1): 131-141, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766363
15.
Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Breast Cancer Res Treat
; 168(2): 551-557, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235045
16.
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.
Breast Cancer Res Treat
; 168(1): 189-196, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29159760
17.
Breast cancer subtype and survival by parity and time since last birth.
Breast Cancer Res Treat
; 169(3): 481-487, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426984
18.
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Support Care Cancer
; 26(3): 869-878, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28963584
19.
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).
Ann Oncol
; 27(9): 1719-25, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27358383
20.
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.
Ann Oncol
; 27(1): 106-13, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26504153